|
Published by: Espicom Healthcare Intelligence
Published: Sep. 30, 2009 - 96 Pages
Table of Contents
- EXECUTIVE SUMMARY
- Introduction
- Pharmaceutical Market Analysis
- Size
- Market Structure
- Pharmaceuticals in Norway are Inexpensive
- Generics
- OTC Products
- Projections
- Outlook
- Imports
- Domestic Production
- Trade Associations
- Domestic Producers
- Axellia Pharmaceuticals AS
- Clavis Pharma ASA
- Pronova BioPharma Norge AS
- Weifa AS
- Multinational Manufacturers
- Fresenius Kabi Norge AS
- Nycomed Pharma AS
- Exports
- Research & Development
- Clinical Trials
- Pharmaceutical Regulatory Analysis
- Pharmaceutical Regulation
- EU Drug Regulation
- Centralised Procedure
- EMEA
- Generic Drugs
- National Procedures
- Marketing Authorisations
- Advertising
- Intellectual Property
- Supplementary Protection Certificates
- Data exclusivity
- Pricing and Reimbursement
- Pricing
- Step-Price System (Trinnpris)
- Generic Substitution
- First-Choice System
- Out-of-Pocket Payments
- Reimbursement
- Pharmaceutical Distribution
- Pharmacies
- Distributors
- Norsk Medisinaldepot AS (NMD)
- Apokjeden Distribusjon AS
- Holtung AS
- Parallel Imports
- Healthcare Analysis
- Demographics
- Population
- Birth Rate
- Death Rate
- Infant Mortality
- Life Expectancy at Birth
- Public Health
- Causes of Death
- Incidence of Communicable Diseases/ Morbidity
- HIV/ AIDS
- Cancer Incidence
- Healthcare System
- Health Expenditure
- Healthcare Infrastructure
- Inpatient Analysis
- Ambulatory Care
- Healthcare Personnel
- DIRECTORY
- Healthcare Organisations
- Distributors
- Trade Associations
- Domestic Producers
- Methodology and Sources
- List of Tables
- Key Data Projections, 2009-2014
- Summary of the Norwegian Pharmaceutical Market, 2009
- Pharmaceutical Market by Type in Retail Prices, 2008
- Pharmaceutical Sales by Therapeutic Group in Wholesale Prices (NOK millions), 2007-2008
- Highest Sales of Prescription-Only Medicines at Retail Prices, 2008
- Top 25 Pharmaceutical Companies by Sales at Wholesale Prices, 2008
- Top 25 Products by Sales at Wholesale Prices, 2008
- OTC Sales by Therapeutic Group at Wholesale Prices (NOK millions), 2008
- Top 10 Companies by OTC Sales at Wholesale Prices, 2008
- Top 25 OTC Drugs at Wholesale Prices, 2008
- Key Market Projections, 2009-2014
- Espicom Analysis of the Norwegian Pharmaceutical Market, 2009
- SWOT Analysis of the Norwegian Pharmaceutical Market, 2009
- Imports of Pharmaceuticals by Category, 2003-2007 (US$000s)
- Import Trends, 2006-2007
- Leading Suppliers of Raw Materials, 2007 (US$000s)
- Leading Suppliers of Retail Medicaments, 2007 (US$000s)
- Exports of Pharmaceuticals, 2003-2007 (US$000s)
- Export Trends, 2006-2007
- Leading Destinations, 2007 (US$000s)
- R&D Expenditure, 2000-2007
- Clinical Trials in the Pharmaceutical Industry, 2007
- Total Active Ingredients, Medicinal Products and Marketing Authorisations, 2003-2008
- Structure of Ownership, 2008
- Ownership of Pharmacies, 2008
- Parallel Imported Drug Sales, 1995-2008
- Summary of Demographic Data, 2008
- Projected Population, 2009-2014
- Causes of Death, 2006-2007
- Out-of-pocket Payments for Healthcare Services, 2009 (NOK)
- Healthcare Expenditure, 2009
- Health Expenditure by Function of Care, 2006-2008 (NOK millions)
- Health Expenditure on Medical Goods Dispensed to Outpatients (NOK millions), 2006-2008
- Projected Health Expenditure, 2009-2014
- Number of Beds by Type of Institution, 2004-2006
- Number of General Hospital Beds by Region, 2004-2007
- Hospital Activity, 2002-2007
- Discharges from General Hospitals by Diagnosis, 2006-2007
- General Hospital Day Cases by Diagnosis, 2007-2008
- General Hospital Outpatient Consultations by Diagnosis, 2007-2008
- Physicians by Specialty, 2008
- FTE Staff in Hospitals by Type of Personnel, 2005-2007
- Dentists & Other Dentistry Staff, 2003-2007
- Projected Total Number of Physicians, 2009-2014
- List of Figures
- Funding of Pharmaceuticals, 2007
- Radar Graph of the Norwegian Pharmaceutical Market, 2009
- Submitted Clinical Trial Applications, 2003-2008
- Pharmacy Market Shares, 2008
AbstractEspicom’s in-depth pharmaceutical market reports are ideal for executives wanting to understand the key drivers in pharmaceutical markets and have access to a wealth of statistical data. Each report opens with an outlook section that provides analysis of the market, 5-year market forecasts, national data projections, market outlook and key developments such as regulation, pricing/reimbursement, intellectual property, health facilities and government policy. The report also provides extensive background information, population trends, health status, health expenditure, organisation & administration, hospital services, medical personnel, healthcare development, market access information, trade data for raw materials and finished products and essential industry contacts.
Please Note: this is delivered as a Zip file.
Get Full Details About This Report >>
|
|
US: 800.298.5699
Int'l: +1.240.747.3093
|
|
|
|
About MarketResearch.com
MarketResearch.com is an online aggregator selling over 250,000 market research reports, company profiles and country profiles from over 650 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.
© MarketResearch.com 2009
|
